These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 31377780)

  • 1. Anti-apolipoprotein A-1 autoantibodies correlate with disease activity in systemic lupus erythematosus.
    Nigolian H; Ribi C; Courvoisier DS; Pagano S; Alvarez M; Trendelenburg M; Huynh-Do U; Vuilleumier N; Dayer JM; Chizzolini C; Roux-Lombard P
    Rheumatology (Oxford); 2020 Mar; 59(3):534-544. PubMed ID: 31377780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased serum thrombospondin-1 and elevation of its autoantibody are associated with multiple exacerbated clinical manifestations in systemic lupus erythematosus.
    Meng Y; Zhang M; Zhao X; Cheng Y; Jia R; Wang Y; Sun X
    Clin Rheumatol; 2018 Oct; 37(10):2707-2714. PubMed ID: 29998369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of anti-CLIC2 and anti-HMGB1 autoantibodies with higher disease activity in systemic lupus erythematosus patients.
    Syahidatulamali CS; Wan Syamimee WG; Azwany YN; Wong KK; Che Maraina CH
    J Postgrad Med; 2017; 63(4):257-261. PubMed ID: 28862243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational study.
    Croca S; Bassett P; Chambers S; Davari M; Alber KF; Leach O; Ioannou Y; Giles I; Isenberg D; Rahman A
    Arthritis Res Ther; 2015 Feb; 17(1):26. PubMed ID: 25890187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-dsDNA titre in female systemic lupus erythematosus patients: relation to disease manifestations, damage and antiphospholipid antibodies.
    Gheita TA; Abaza NM; Hammam N; Mohamed AAA; El-Gazzar II; Eissa AH
    Lupus; 2018 Jun; 27(7):1081-1087. PubMed ID: 29460701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a new fluorescence immunoassay to detect anti-dsDNA antibodies is more correlated with disease activity and complement than the ELISA method in SLE patients.
    Chen CY; Tseng HM; Chen LC; Tsao CH; Kuo ML; Ou LS; Huang JL
    Lupus; 2003; 12(4):266-73. PubMed ID: 12729049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-dsDNA and Antichromatin Antibody Isotypes in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus.
    Steiman AJ; Urowitz MB; Ibañez D; Li TT; Gladman DD; Wither J
    J Rheumatol; 2015 May; 42(5):810-6. PubMed ID: 25729033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity.
    Aggarwal R; Sequeira W; Kokebie R; Mikolaitis RA; Fogg L; Finnegan A; Plaas A; Block JA; Jolly M
    Arthritis Care Res (Hoboken); 2011 Jun; 63(6):891-8. PubMed ID: 21312346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
    de Carvalho JF; Borba EF; Viana VS; Bueno C; Leon EP; Bonfá E
    Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum antibodies to human leucocyte antigen (HLA)-E, HLA-F and HLA-G in patients with systemic lupus erythematosus (SLE) during disease flares: Clinical relevance of HLA-F autoantibodies.
    Jucaud V; Ravindranath MH; Terasaki PI; Morales-Buenrostro LE; Hiepe F; Rose T; Biesen R
    Clin Exp Immunol; 2016 Mar; 183(3):326-40. PubMed ID: 26440212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
    J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies Against Albumin in Patients With Systemic Lupus Erythematosus.
    Nehring J; Schirmbeck LA; Friebus-Kardash J; Dubler D; Huynh-Do U; Chizzolini C; Ribi C; Trendelenburg M
    Front Immunol; 2018; 9():2090. PubMed ID: 30333817
    [No Abstract]   [Full Text] [Related]  

  • 14. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
    Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum anti-lipocalin 2 IgG is a novel biomarker in the diagnosis of systemic lupus erythematosus.
    Li YN; Hu FL; Dai YJ; Li R; Ma XX; Du Y; Feng M; Jia Y; Zhang CF; Zhu L; Ascherman DP; Li ZG
    Lupus; 2014 Aug; 23(9):868-75. PubMed ID: 24704774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus.
    Zivković V; Stanković A; Cvetković T; Mitić B; Kostić S; Nedović J; Stamenković B
    Srp Arh Celok Lek; 2014; 142(7-8):431-6. PubMed ID: 25233687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus.
    Cavazzana I; Kumar R; Pozzari C; Ottaviani R; Fredi M; Piantoni S; Andreoli L; Tincani A; Franceschini F
    Lupus; 2019 Aug; 28(9):1074-1081. PubMed ID: 31296140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-apolipoprotein A-I autoantibody: characterization of monoclonal autoantibodies from patients with systemic lupus erythematosus.
    Abe H; Tsuboi N; Suzuki S; Sakuraba H; Takanashi H; Tahara K; Tonozuka N; Hayashi T; Umeda M
    J Rheumatol; 2001 May; 28(5):990-5. PubMed ID: 11361227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis.
    Hardt U; Larsson A; Gunnarsson I; Clancy RM; Petri M; Buyon JP; Silverman GJ; Svenungsson E; Grönwall C
    Arthritis Res Ther; 2018 Feb; 20(1):36. PubMed ID: 29482604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q.
    Mok CC; Birmingham DJ; Ho LY; Hebert LA; Song H; Rovin BH
    Lupus; 2012 Jan; 21(1):36-42. PubMed ID: 21993384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.